Science Explorer Back to mapMap
Discussion
Topic · Surgery

Testicular diseases and treatments

Testicular diseases and treatments is a research topic within Surgery. Science Explorer counts 25k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on testicular germ cell tumors, covering topics such as diagnosis, treatment, long-term survival, chemotherapy, risk factors, and genetic aspects. It also explores complications, including cardiovascular disease, associated with the treatment of testicular cancer.

  • Testicular Cancer
  • Germ Cell Tumors
  • Survivors
  • Chemotherapy
  • Diagnosis
  • Treatment
  • Risk Factors
  • Cryptorchidism
  • Long-Term Complications
  • Genetic Factors
Research works
25k
fractional, since 1950
In the world top 10%
2.5k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+3%
the tick is no change
Largest producer
United States
27% of the 10 largest, 2022-now
Testicular diseases and treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Testicular diseases and treatments research?

By volume, the United States and China publish the most (666 and 489 works in 2022-now).

By volume, 2022-now

  1. 1 United States 666 works
  2. 2 China 489 works
  3. 3 India 341 works
  4. 4 Japan 186 works
  5. 5 Türkiye 175 works
  6. 6 Germany 158 works
  7. 7 United Kingdom 140 works
  8. 8 Italy 133 works
  9. 9 Brazil 89 works
  10. 10 France 84 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 27.1%China: 19.9%India: 13.9%Japan: 7.6%6 others listed: 31.6%27%largest
United States666 · 27.1%China489 · 19.9%India341 · 13.9%Japan186 · 7.6%6 others listed778 · 31.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Testicular diseases and treatments research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Testicular diseases and treatments research, followed by Indiana University and Harvard University.

Who are the leading researchers in Testicular diseases and treatments?

The most-cited researchers publishing on Testicular diseases and treatments include Ahmedin Jemal, Freddie Bray and Elaine R. Mardis.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Elaine R. Mardis United States 346k citations
  4. 4 Hermann Brenner Germany 343k citations
  5. 5 Richard A. Gibbs United States 292k citations
  6. 6 Gordon Brent Mills United States 265k citations
  7. 7 Jean‐Louis Vincent Belgium 262k citations
  8. 8 Carlo La Vecchia Italy 258k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Testicular diseases and treatments?

The most cited paper in Testicular diseases and treatments is "The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours" (Holger Moch, Antonio L. Cubilla, Peter A. Humphrey et al., 2016), with 3,191 citations. Next come "Consensus Statement on Management of Intersex Disorders" (2,327) and "Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion" (2,271).

Most cited papers
#PaperReleasedCitations
1 The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours Holger Moch, Antonio L. Cubilla, Peter A. Humphrey et al. · European Urology 28 Feb 2016 3,191
2 Consensus Statement on Management of Intersex Disorders Peter A. Lee, Christopher P. Houk, S. Faisal Ahmed et al. · PEDIATRICS Aug 2006 2,327
3 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion N E Skakkebæk, Ewa Rajpert‐De Meyts, Katharina Maria Main · Human Reproduction May 2001 2,271
4 Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer Lawrence H. Einhorn, John Paul Donohue · Annals of Internal Medicine Sep 1977 1,560
5 Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood RM Sharpe, Chris McKinnell, C Kivlin et al. · Reproduction Jun 2003 1,249
All 100 most cited papers, with filters and sorting

Where is Testicular diseases and treatments research done?

The largest centres of Testicular diseases and treatments research in 2022-now are Beijing (China), London (United Kingdom), Istanbul (Türkiye) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Indianapolis.

Largest cities, 2022-now

  1. 1 BeijingChina 60 works
  2. 2 LondonUnited Kingdom 49 works
  3. 3 IstanbulTürkiye 48 works
  4. 4 New DelhiIndia 41 works
  5. 5 TokyoJapan 36 works
  6. 6 New YorkUnited States 35 works
  7. 7 GuangzhouChina 34 works
  8. 8 MumbaiIndia 34 works
  9. 9 AnkaraTürkiye 32 works
  10. 10 ShanghaiChina 31 works

Where it is the local speciality

  1. IndianapolisUS · 28.4 works12×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Testicular diseases and treatments than the world average.

See Testicular diseases and treatments on the map

Where is the best place to study Testicular diseases and treatments?

Among universities, judged by research, Indiana University, Harvard University and University of Copenhagen score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.68%fractional works in this field (log) →share of work in the world top 10% →University of Copenh…Indiana UniversityCornell UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Indiana UniversityUnited States 77.323.2%10.6×34 -21.4%
2Harvard UniversityUnited States 67.220.2%2.3×24 -6.6%
3University of CopenhagenDenmark 65.229.7%3.7×11 -4.6%
4Cornell UniversityUnited States 53.021.5%3.0×13 -10.7%
5University of CologneGermany 52.518.9%8.5×12 -0.6%
6Peking UniversityChina 52.423.8%1.9×13 +87.6%
7Sichuan UniversityChina 51.313.6%2.8×21 +46.8%
8All India Institute of Medical SciencesIndia 50.84.6%9.3×34 +5.1%
9Universität HamburgGermany 50.323.0%4.3×10 -5.9%
10Zhejiang UniversityChina 49.918.3%1.8×16 +57.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Testicular diseases and treatments, country by country

Is Testicular diseases and treatments research growing?

Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Testicular diseases and treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Testicular diseases and treatments as a percentage of every work published that year, 0.016% in 2024.

still counting0.020%0.040%0.060%Testicular diseases and treatments0.015% in 202519801990200020102020

Fractional works of Testicular diseases and treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Testicular diseases and treatments10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Testicular diseases and treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.